Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 4,549-4,560 of 10,612

Drug study icon

WithdrawnNCT04311619

Does rTMS Induce Synaptic Plasticity?

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Davidzon, Guido, M.D.
Condition: Depression

Behavioral study icon

CompletedNCT00306475

Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?

This study is completed in the United States. It focuses on schizophrenia.

In United States

SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Northwestern University
Condition: Schizophrenia

Drug study icon

WithdrawnNCT05060549

Dopamine D3 Receptor Occupancy in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT02560389

Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 25 Years to 50 Years

Countries: United States
Sponsor: University of Wisconsin, Madison
Condition: PTSD

Other study type icon

CompletedNCT01035996

Dopamine Function and Reward Processing In Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaObservationalFrom 18 Years to 50 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Schizophrenia

Drug study icon

CompletedNCT04128683

Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 29 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Eating disorders

Other study type icon

CompletedNCT00116077

Dopamine Receptor Imaging in Mood Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, BipolarityObservationalFrom 18 Years to 55 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression, Bipolarity

Drug study icon

CompletedNCT02225106

Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: ADHD

Drug study icon

WithdrawnNCT02233829

Dopamine Rhythms in Health and Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 55 Years

Countries: United States
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition: Addiction

Drug study icon

CompletedNCT04469959

Dopaminergic Dysfunction in Late-Life Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugOver 60 Years

Countries: United States
Sponsor: Vanderbilt University Medical Center
Condition: Depression

Drug study icon

WithdrawnNCT02929485

Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: University of California, Berkeley
Condition: Addiction

Drug study icon

CompletedNCT02255565

Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 5 Years to 16 Years

Countries: United States
Sponsor: Seattle Children's Hospital
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.